NCT05538910View on ClinicalTrials.gov

Defining Neurobiological Links Between Substance Use and Mental Illness

NARecruitingINTERVENTIONAL
Enrollment

620

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

December 30, 2027

Study Completion Date

December 31, 2027

Conditions
Major Depressive DisorderSubstance Use DisorderNormal Physiology
Interventions
OTHER

Placebo Nicotine Patch

Comparator

DRUG

Nicotine Patch

Study drug: 7.5 mg Nicotine Patch which will be administered in a double blind, randomized manner

Trial Locations (1)

21224

RECRUITING

National Institute on Drug Abuse, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH